Pharmacy Clawbacks

Limit on drug industry middlemen affects local pharmacy

By Bethany Wagoner
Posted 12/4/23

The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring. Instead of helping …

This item is available in full to subscribers.

Please log in to continue

E-mail or username
Log in